BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 23079663)

  • 21. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
    Gooptu M; Whitaker-Menezes D; Sprandio J; Domingo-Vidal M; Lin Z; Uppal G; Gong J; Fratamico R; Leiby B; Dulau-Florea A; Caro J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):204-217. PubMed ID: 29248132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.
    Wang WG; Liu ZB; Jiang XN; Lee J; Zhou XY; Li XQ
    Histopathology; 2017 Nov; 71(5):778-785. PubMed ID: 28639315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
    Wilson WH; Young RM; Schmitz R; Yang Y; Pittaluga S; Wright G; Lih CJ; Williams PM; Shaffer AL; Gerecitano J; de Vos S; Goy A; Kenkre VP; Barr PM; Blum KA; Shustov A; Advani R; Fowler NH; Vose JM; Elstrom RL; Habermann TM; Barrientos JC; McGreivy J; Fardis M; Chang BY; Clow F; Munneke B; Moussa D; Beaupre DM; Staudt LM
    Nat Med; 2015 Aug; 21(8):922-6. PubMed ID: 26193343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas.
    Białopiotrowicz-Data E; Noyszewska-Kania M; Jabłońska E; Sewastianik T; Komar D; Dębek S; Garbicz F; Wojtas M; Szydłowski M; Polak A; Górniak P; Juszczyński P
    Cell Death Dis; 2023 Oct; 14(10):667. PubMed ID: 37816710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.
    Jablonska E; Gorniak P; Szydlowski M; Sewastianik T; Bialopiotrowicz E; Polak A; Warzocha K; Juszczynski P
    Exp Hematol; 2017 Feb; 46():56-61.e1. PubMed ID: 27720936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival.
    Li M; Teater MR; Hong JY; Park NR; Duy C; Shen H; Wang L; Chen Z; Cerchietti L; Davidson SM; Lin H; Melnick AM
    Blood Cancer Discov; 2022 Jan; 3(1):50-65. PubMed ID: 35019856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.
    Bogusz AM; Kovach AE; Le LP; Feng D; Baxter RH; Sohani AR
    PLoS One; 2017; 12(2):e0172364. PubMed ID: 28212447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse large B-cell lymphoma with low
    Sheng D; Li T; Wang WG; Li MJ; Jiang KL; Gao AH; Li J; Zhou XY; Li XQ
    Leuk Lymphoma; 2020 Jun; 61(6):1364-1371. PubMed ID: 32090646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
    Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
    Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
    Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells.
    Jabłońska E; Białopiotrowicz E; Szydłowski M; Prochorec-Sobieszek M; Juszczyński P; Szumera-Ciećkiewicz A
    Exp Hematol; 2020 Aug; 88():56-67.e2. PubMed ID: 32702393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular signatures define new rational treatment targets in large B-cell lymphomas.
    Shipp MA
    Hematology Am Soc Hematol Educ Program; 2007; ():265-9. PubMed ID: 18024639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
    Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
    Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
    Hu S; Xu-Monette ZY; Balasubramanyam A; Manyam GC; Visco C; Tzankov A; Liu WM; Miranda RN; Zhang L; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhao X; Winter JN; Zhang M; Li L; Møller MB; Piris MA; Li Y; Go RS; Wu L; Medeiros LJ; Young KH
    Blood; 2013 Apr; 121(14):2715-24. PubMed ID: 23343832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
    Li L; Zhang J; Chen J; Xu-Monette ZY; Miao Y; Xiao M; Young KH; Wang S; Medeiros LJ; Wang M; Ford RJ; Pham LV
    Blood; 2018 Oct; 132(17):1805-1817. PubMed ID: 30209121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
    Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
    J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
    Twa DDW; Mottok A; Savage KJ; Steidl C
    Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells.
    Zhu L; Tang F; Lei Z; Guo C; Song Y; Huang J; Xia X
    Mol Carcinog; 2019 Dec; 58(12):2340-2352. PubMed ID: 31556968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Catenin regulates hepatic mitochondrial function and energy balance in mice.
    Lehwald N; Tao GZ; Jang KY; Papandreou I; Liu B; Liu B; Pysz MA; Willmann JK; Knoefel WT; Denko NC; Sylvester KG
    Gastroenterology; 2012 Sep; 143(3):754-764. PubMed ID: 22684045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.